The Journal for Nurse Practitioners
Volume 6, Issue 3 , Pages 220-221 , March 2010

Cholinesterase Inhibitors and Alzheimer Disease

  • Maren S. Mayhew

      Affiliations

    • Maren Mayhew, MS, ANP, GNP, is the author and editor of Pharmacology for Primary Care Providers, a textbook for NPs published by Mosby.

References 

  1. Gill SS , Anderson GM , Fischer HD , et al.   Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors . Arch Intern Med . 2009;169(9):867–873
  2. Rockwood K , Fay S , Song X , MacKnight C , Gorman M . Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial . Can Med Assoc J . 2006;174(8):1099–1105
  3. Howard RJ , Juszczak E , Ballard CG , et al.   Donepezil for the treatment of agitation in Alzheimer's disease . N Engl J Med . 2007;357(14):1382–1392
  4. Farlow MR , Cummings JL . Effective pharmacologic management of Alzheimer's disease . Am J Med . 2007;120:388–397
  5. Hogan DB , Bailey P , Black S , et al.   Diagnosis and treatment of dementia: nonpharmacologic and pharmacologic therapy for mild to moderate dementia . Can Med Assoc J . 2008;179(10):1019–1026
  6. Alzheimer's Association  . FDA-Approved Treatments for Alzheimer's. Topic Sheet . Available at: www.alz.org
  7. Ballard C , Hanney ML , Theodoulou M , et al.   The dementia antipsychotic withdrawal trial (Dart-AD): long-term follow-up of a randomized placebo-controlled trial . Lancet Neurol . 2009;8:151–157

 Suggestions for topics are welcome.

PII: S1555-4155(10)00030-9

doi: 10.1016/j.nurpra.2010.01.009

The Journal for Nurse Practitioners
Volume 6, Issue 3 , Pages 220-221 , March 2010

Article Tools